Browsing Over 443 Presentations
Sort By
My patient has stage IIIA (N2) disease: Surgery or radiotherapy?
Multidisciplinary Tumour Board
My patient needs chemoradiotherapy and durvalumab
Lecture Time
15:34 - 16:01
Speakers
- D. De Ruysscher (Maastricht, Netherlands)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
- D. De Ruysscher (Maastricht, Netherlands)
Early detection, screening, prevention
Educational session
Q&A
Lecture Time
15:21 - 15:24
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Early detection, screening, prevention
Educational session
Primary prevention European campaigns
Lecture Time
14:30 - 14:45
Speakers
- S. Novello (Orbassano, Italy)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
- S. Novello (Orbassano, Italy)
Current management of early stage NSCLC
Educational session
Early stage lung cancer: Progress in TNM
Lecture Time
14:30 - 14:50
Speakers
- R. Rami-Porta (Terrassa, Barcelona, Spain)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
- R. Rami-Porta (Terrassa, Barcelona, Spain)
Early detection, screening, prevention
Educational session
Early detection of mesothelioma and lung cancer in ultra-high risk populations using a biomarker approach
Lecture Time
15:24 - 15:39
Speakers
- T. Behrens (Bochum, Germany)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
- T. Behrens (Bochum, Germany)
Optimising treatment in stage III
Educational session
What is the role of surgery for stage III patients in the I-O era?
Lecture Time
17:10 - 17:30
Speakers
- P. Van Schil (Edegem, Belgium)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
- P. Van Schil (Edegem, Belgium)
Proffered Paper session I
Proffered Paper session
Invited Discussant 68O and 69O
Lecture Time
17:00 - 17:15
Speakers
- A. Dingemans (Maastricht, Netherlands)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:15
Authors
- A. Dingemans (Maastricht, Netherlands)
NSCLC stage IV oncogenic addicted disease
Educational session
Targeted therapy beyond EGFR, ALK and ROS1
Lecture Time
17:10 - 17:30
Speakers
- D. Planchard (Villejuif, France)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
- D. Planchard (Villejuif, France)
Optimising treatment in stage III
Educational session
Innovative radiotherapy approaches for stage III NSCLC patients
Lecture Time
17:30 - 17:50
Speakers
- H. Choy (Dallas, TX, United States of America)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
- H. Choy (Dallas, TX, United States of America)
Proffered Paper session I
Proffered Paper session
Invited Discussant 83O, LBA2 and LBA4
Lecture Time
18:00 - 18:15
Speakers
- F. Barlesi (Marseille, CEDEX 20, France)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:15
Authors
- F. Barlesi (Marseille, CEDEX 20, France)
NSCLC stage IV oncogenic addicted disease
Educational session
Immunotherapy in oncogenic addicted NSCLC
Lecture Time
17:30 - 17:50
Speakers
- J. Mazieres (Toulouse, France)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
- J. Mazieres (Toulouse, France)
Optimising treatment in stage III
Educational session
Q&A
Lecture Time
17:50 - 18:00
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00